专利号:US-2008032964-A1 优先权日:2006-04-10 标题:Process for the synthesis of azetidinone 发明人:KANSAL VINOD K; AHMAD SUHAIL; MARIAPPAN SHANMUGAVEL; TYAGI BHUPENDRA; PERLMAN NURIT; LE PAIH JACQUES; ZANOTTI-GEROSA ANTONIO 权利人:KANSAL VINOD K; AHMAD SUHAIL; MARIAPPAN SHANMUGAVEL; TYAGI BHUPENDRA; PERLMAN NURIT; LE PAIH JACQUES; ZANOTTI-GEROSA ANTONIO 摘要:Provided are intermediates useful for the synthesis of hydroxyl-alkyl substituted azetidinones, processes of their preparation, and processes for the synthesis of certain hydroxyl-alkyl substituted azetidinones. Also provided are processes for the synthesis of 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone, or ezetimibe.
专利号:US-6251689-B1 优先权日:1998-05-14 标 题:Methods for the solid phase synthesis of combinatorial libraries of benzimidazoles benzoxazoles benzothiazoles and derivatives thereof 发明人:LABORDE EDGARDO; MATSUMOTO YUKIHARU 权利人:TELIK INC 摘要:The present invention provides an efficient and versatile method for the synthesis and screening of combinatorial libraries of benzimidazoles, benzoxazoles, benzothiazoles, and derivatives thereof. In order to expedite the synthesis of large arrays of compounds possessing these core structures, a general methodology for solid phase synthesis of these derivatives is provided. Arrays of benzimidazoles, benzoxazoles, benzothiazoles, and derivatives thereof useful as peptidomimetics and for the identification of agents having antifungal, antiviral, antimicrobial, anticoagulant, and antiulcer activity, or use in the treatment of inflammation, hypertension, cancer, and other conditions can be prepared by this method.
专利号:US-5861532-A 优先权日:1997-03-04 标 题:Solid-phase synthesis of N-alkyl amides 发明人:BROWN EDWARD G; NUSS JOHN M 权利人:CHIRON CORP 摘要:Methods for solid phase synthesis of N-alkyl amides comprise reductive amination of carbonyl compounds using a reducing agent and an amine-containing linker bound to a solid support. The methods afford high yields of linker-bound, monoalkylated amines, and subsequent coupling with acid derivatives provide derivatized N-substituted amides in excellent yields after cleavage from the solid-phase. Compositions useful in solid phase synthesis are also described.
专利号:US-6177564-B1 优先权日:1998-09-11 标题:Process for the synthesis of N-benzyl-3-(4-fluorophenyl)-1-4-oxazin-2-one 发明人:NELSON TODD D; BHUPATHY MAHADEVAN 权利人:MERCK & CO INC 摘要:The present invention is concerned with a novel process for the preparation of N-benzyl-3-(4-fluorophenyl)-1,4-oxazin-2-one of the formula:This compound is useful as an intermediate in the synthesis of compounds which possess pharmacological activity, in particular, as substance P (neurokinin-1) receptor antagonists.
专利号:US-2009270630-A1 优先权日:2006-06-23 标题:Process for the synthesis of benzylidene rosiglitazone base 发明人:CZIBULA LASZLO; SEBOK FERENC; DOBAY LASZLO; WERKNE PAPP EVA; DEUTSCHNE JUHASZ IDA; NAGYNE BAGDY JUDIT; UBERHARDT TAMASNE 权利人:CZIBULA LASZLO; SEBOK FERENC; DOBAY LASZLO; WERKNE PAPP EVA; DEUTSCHNE JUHASZ IDA; NAGYNE BAGDY JUDIT; UBERHARDT TAMASNE 摘要:Process for the synthesis of 5-{4-[N-methyl-N-(2-pyridyl)-amino-ethoxy]-benzylidene}-thiazolidine-2,4-dione (INN name: benzylidene-rosiglitazone) of formula (I), which consist of the following steps: n n n n n n n n n n n n Step a) reaction of 2-chloro-pyridine and 2-(N-methylamino)-ethanol n Step b) reaction of the obtained compound of formula (III) with 4-fluorobenzaldehyde n Step c) reaction of the obtained compound of formula (IV) with thiazolidine-2,4-dione n n n n n n n n n n n n n n characterized byn dissolving 4-{2-[N-methyl-N-(2-pyridyl)amino]-ethanol of formula (III) obtained in Step a) in toluene and using it in Step b) without isolation; reacting the solution of compound of formula (III) in toluene in Step b) with 4-fluorobenzaldehyde in the presence of aqueous alkali hydroxide solution and phase transfer catalyst at 25-50° C.; reacting the solution of the benzaldehyde derivative of formula (IV) obtained in Step b) in toluene in Step c) and isolating the desired product.
专利号:US-10266565-B2 优先权日:2011-04-12 标 题 :Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use 发明人:BURKE JR TERRENCE R; LIU FA; LEE KYUNG S; PARK JUNG-EUN 权利人:BURKE JR TERRENCE R; LIU FA; LEE KYUNG S; PARK JUNG EUN; THE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES 摘要:Novel compounds are provided that bind to polo-like kinases through the polo-box domain. In certain embodiments, the novel compounds are PEGylated peptides. The PEGylated peptides in accordance with the invention demonstrate high PBD-binding affinity. In certain embodiments, the PEGylated peptides have also achieved activities in whole cell systems. The invention also provides compounds that bind polo-like kinases through the polo-box domain and possess reduced anionic charge. Further provided are methods of design and/or synthesis of the PEGylated peptides and methods of use thereof. The invention provides methods of use of the compounds and methods of synthesis of the compounds.
[参考文献]: Xuemei Tian, Et Al. First Novozym 435 Lipase-Catalyzed Morita-Baylis-Hillman Reaction In The Presence Of Amides. Enzyme Microb Technol. 2016 Mar:84:32-40.
合成参考文献
参考文献:10.1107/s1600536811008786 摘要:Huang JY, Zhou F. 4,5-Bis(4-fluoro-phen-yl)-5-hy-droxy-3-(2-methyl-propano-yl)-1-phenyl-pyrrolidin-2-one. Acta Crystallogr Sect E Struct Rep Online. 2011 Apr 01;67(Pt 4):o873–4. 参考文献:10.1107/s1600536811012098 摘要:Rosepriya S, Thiruvalluvar A, Jayabharathi J, Srinivasan N, Butcher RJ, Jasinski JP, Golen JA. 1-(3,5-Dimethyl-phenyl)-2-(4-fluoro-phenyl)-4,5-dimethyl-1H-imidazole. Acta Crystallogr Sect E Struct Rep Online. 2011 May 01;67(Pt 5):o1065. 参考文献:10.1107/s1600536811018332 摘要:Watanabe S, Muto T, Nagasawa A, Okamoto A, Yonezawa N. (2,7-Dimeth-oxy-naphthalen-1-yl)(4-fluoro-phen-yl)methanone. Acta Crystallogr Sect E Struct Rep Online. 2011 Jun 01;67(Pt 6):o1466. 参考文献:10.1007/s00259-011-1879-9 摘要:Miao Z, Ren G, Jiang L, Liu H, Webster JM, Zhang R, Namavari M, Gambhir SS, Syud F, Cheng Z. A novel 18F-labeled two-helix scaffold protein for PET imaging of HER2-positive tumor. European Journal of Nuclear Medicine and Molecular Imaging. 2011 Jul 15;38(11):1977. doi: 10.1007/s00259-011-1879-9.